Cargando…

Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study

PURPOSE: The extended role of breast-conserving surgery (BCS) in the neoadjuvant setting may raise concerns on the oncologic safety of BCS compared to mastectomy. This study compared long-term outcomes after neoadjuvant chemotherapy (NAC) between patients treated with BCS and mastectomy. METHODS: Al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simons, Janine M., Jacobs, Julien G., Roijers, Joost P., Beek, Maarten A., Boonman-de Winter, Leandra J. M., Rijken, Arjen M., Gobardhan, Paul D., Wijsman, Jan H., Tetteroo, Eric, Heijns, Joan B., Yick, C. Y., Luiten, Ernest J. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867515/ https://www.ncbi.nlm.nih.gov/pubmed/33073303 http://dx.doi.org/10.1007/s10549-020-05966-y

Ejemplares similares

Breast sensibility after mastectomy and implant-based breast reconstruction
por: Bijkerk, E., et al.
Publicado: (2019)

De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study
por: Simons, J. M., et al.
Publicado: (2020)

Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
por: Wang, Xiaofang, et al.
Publicado: (2021)

Predictors of patients’ choices for breast-conserving therapy or mastectomy: a prospective study
por: Molenaar, S, et al.
Publicado: (2004)

Talc seromadesis in patients with chronic seroma formation after breast surgery
por: Catsman, Coriene J. L. M., et al.
Publicado: (2016)

Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial
por: Lugtenberg, Rieneke T., et al.
Publicado: (2020)

Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience
por: Vriens, Ingeborg J. H., et al.
Publicado: (2020)

The influence of neoadjuvant chemotherapy on complications of immediate DIEP flap breast reconstructions
por: Beugels, J., et al.
Publicado: (2019)

The impact of neoadjuvant systemic treatment on postoperative complications in breast cancer surgery
por: Nussbaumer, R. L., et al.
Publicado: (2022)

Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer
por: Rugo, Hope S., et al.
Publicado: (2021)

Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer: A Systematic Review and Meta-analysis
por: Simons, Janine M., et al.
Publicado: (2019)

The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial
por: Klompenhouwer, Elisabeth G, et al.
Publicado: (2013)

The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery
por: Collarino, Angela, et al.
Publicado: (2018)

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer
por: Vriens, B. E. P. J., et al.
Publicado: (2017)

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry
por: Meegdes, Marissa, et al.
Publicado: (2022)

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
por: Förnvik, Daniel, et al.
Publicado: (2019)

Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
por: Verreck, Eline E. F., et al.
Publicado: (2023)

Breast sensibility in bilateral autologous breast reconstruction with unilateral sensory nerve coaptation
por: Bijkerk, Ennie, et al.
Publicado: (2020)

Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients
por: Jacobs, D. H. M., et al.
Publicado: (2018)

nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2– metastatic breast cancer
por: Hamilton, Erika, et al.
Publicado: (2022)

Evaluation of changes to foot shape in females 5 years after mastectomy: a case–control study
por: Głowacka-Mrotek, Iwona, et al.
Publicado: (2017)

Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
por: Taylor, Caitlin, et al.
Publicado: (2023)

Minimally invasive breast cancer excision using the breast lesion excision system under ultrasound guidance
por: Sanderink, W. B. G., et al.
Publicado: (2020)

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
por: de Groot, S., et al.
Publicado: (2015)

Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry
por: Iwamoto, Takayuki, et al.
Publicado: (2016)

Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
por: Skarping, Ida, et al.
Publicado: (2021)

Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial
por: Parker, Barbara A., et al.
Publicado: (2023)

Prognostic impact of breast cancer subtypes in elderly patients
por: Bergen, E. S., et al.
Publicado: (2016)

Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
por: Goorts, Briete, et al.
Publicado: (2017)

Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands
por: Walstra, Coco J. E. F., et al.
Publicado: (2021)

Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18)
por: Finn, Richard S., et al.
Publicado: (2020)

Robot-assisted Nipple Sparing Mastectomy: Recent Advancements and Ongoing Controversies
por: Park, Ko Un, et al.
Publicado: (2023)

Evaluating the Effectiveness of Neoadjuvant Chemotherapy in Reducing Mastectomy for Women With Breast Cancer
por: Mohiuddin, Jahan J., et al.
Publicado: (2017)

Evolution of radical mastectomy for breast cancer
por: Plesca, M, et al.
Publicado: (2016)

Breast Reconstruction after Mastectomy
por: Schmauss, Daniel, et al.
Publicado: (2016)

Predictive risk factors of complications in different breast reconstruction methods
por: Palve, J. S., et al.
Publicado: (2020)

Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?
por: Schaefgen, Benedikt, et al.
Publicado: (2021)

The impact of high-intensity interval exercise training on NK-cell function and circulating myokines for breast cancer prevention among women at high risk for breast cancer
por: Coletta, Adriana M., et al.
Publicado: (2021)

High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2014)

Objective breast symmetry analysis with the breast analyzing tool (BAT): improved tool for clinical trials
por: Krois, Wilfried, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_453hhcld1r9ca4tqv59sd6ku96